Drugs in development for the treatment of multiple sclerosis: Antigen non-specific therapies - An update

Expert Opinion on Investigational Drugs

Volumn 9, Issue 1, 2000, Pages 167-171

  Donoghue, S ^a   Greenlees, C ^a  

^a Elan Pharmaceuticals   (United Kingdom)

Author keywords

Clinical trials; Multiple sclerosis; New treatments; interferon

Indexed keywords

BETA1A INTERFERON; CLADRIBINE; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MITOXANTRONE; MONOCLONAL ANTIBODY; NATALIZUMAB; ROQUINIMEX; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; HUMAN; MULTIPLE SCLEROSIS; SHORT SURVEY; SIDE EFFECT;

EID: 0033988511     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.1.167     Document Type: Short Survey

References (12)